熱門資訊> 正文
Augmedix将被Commure收购，交易估值约为1.39亿美元
2024-07-19 19:26
- Augmedix (NASDAQ:AUGX) said on Friday that it is set to be acquired by the healthcare technology solutions provider Commure in an all-cash transaction, valuing the former at ~$139M.
- AUGX shareholders are set to receive $2.35 per share in cash, representing a premium of ~169% over the volume weighted average price of the company's shares for the 30 days ending July 18.
- Augmedix's board has unanimously approved the transaction.
- The transaction, expected to close in late Q3 or early Q4, is set to be funded from Commure's cash on hand and available liquidity.
- AUGX shares were trading +2.95% pre-market.
- Source: Press Release
More on Augmedix
- Augmedix, Inc. 2024 Q1 - Results - Earnings Call Presentation
- Augmedix, Inc. (AUGX) Q1 2024 Earnings Call Transcript
- Augmedix crashes as Evercore downgrades after guidance cut
- Seeking Alpha’s Quant Rating on Augmedix
- Historical earnings data for Augmedix
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
